skinny-label
3 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 24-889 | Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al. | Federal Circuit | 2025-02-19 | Granted | CVSGAmici (11)Relisted (3) | carve-out generic-drugs hatch-waxman-act induced-infringement patent-infringement skinny-label | 1. When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cit… |
| 24A652 | Hikma Pharmaceuticals USA Inc., et al. v. Amarin Pharma, Inc., et al. | Federal Circuit | 2024-12-31 | Presumed Complete | generic-drug hatch-waxman-act induced-infringement patent-infringement section-viii skinny-label | Question not identified. | |
| 22-37 | Teva Pharmaceuticals USA, Inc. v. GlaxoSmithKline LLC, et al. | Federal Circuit | 2022-07-13 | Denied | CVSGAmici (5)Relisted (3) | active-inducement fda-approval generic-drug generic-drugs hatch-waxman-act inducement-doctrine patent-infringement skinny-label | If a generic drug's FDA-approved label carves out all of the language that the brand manufacturer has identified as covering its patented uses, can th… |